TRAF4-mediated nonproteolytic ubiquitination of androgen receptor promotes castration-resistant prostate cancer

Ramesh Singh1, Huan Meng1, Tao Shen1

  • 1Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030.

Insights

TRAF4 E3 ligase drives castration-resistant prostate cancer (CRPC) by altering androgen receptor (AR) binding. This atypical ubiquitination promotes AR

Area of Science:

  • Molecular Oncology
  • Cancer Biology
  • Ubiquitination Signaling

Background:

  • Castration-resistant prostate cancer (CRPC) remains a clinical challenge, with the androgen receptor (AR) as a key driver.
  • AR induces distinct transcriptional programs in CRPC after androgen deprivation, but the underlying mechanisms are unclear.
  • Understanding AR's genomic binding and its role in CRPC development is crucial for therapeutic strategies.

Purpose of the Study:

  • To elucidate the mechanism by which AR binds to distinct genomic loci in CRPC.
  • To investigate the role of atypical ubiquitination in AR-mediated transcriptional reprogramming in CRPC.
  • To identify novel therapeutic targets for castration-resistant prostate cancer.

Main Methods:

  • Investigated the role of E3 ubiquitin ligase TRAF4 in CRPC development.
  • Analyzed AR ubiquitination status, specifically K27-linked ubiquitination, and its effect on AR-FOXA1 interaction.
  • Examined AR binding to genomic loci and subsequent transcriptional changes, including olfactory transduction pathways.

Main Results:

  • TRAF4 is highly expressed in CRPC and promotes tumor development.
  • TRAF4 mediates K27-linked ubiquitination of AR, enhancing its association with FOXA1.
  • TRAF4-mediated AR reprogramming drives olfactory receptor gene transcription, increasing cAMP and E2F activity, promoting proliferation in castration conditions.

Conclusions:

  • Atypical ubiquitination of AR by TRAF4 is a key posttranslational mechanism driving AR-regulated transcriptional reprogramming in CRPC.
  • TRAF4 facilitates AR binding to specific genomic sites, promoting cell survival and proliferation under androgen deprivation.
  • Targeting TRAF4-mediated ubiquitination may offer a novel therapeutic strategy for castration-resistant prostate cancer.

Related Concept Videos

Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.4K
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
79.0K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.7K
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
6.2K